Cargando…

Tumor Delivery of Chemotherapy Combined with Inhibitors of Angiogenesis and Vascular Targeting Agents

Numerous angiogenesis-vascular targeting agents have been admitted to the ranks of cancer therapeutics; most are used in polytherapy regimens. This review looks at recent progress and our own preclinical experience in combining angiogenesis inhibitors, mainly acting on VEGF/VEGFR pathways, and vascu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cesca, Marta, Bizzaro, Francesca, Zucchetti, Massimo, Giavazzi, Raffaella
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2013
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3787308/ https://www.ncbi.nlm.nih.gov/pubmed/24102047 http://dx.doi.org/10.3389/fonc.2013.00259

Ejemplares similares

Combination therapy in cancer: effects of angiogenesis inhibitors on drug pharmacokinetics and pharmacodynamics
por: Fuso Nerini, Ilaria, et al.
Publicado: (2016)

Sequence dependent antitumour efficacy of the vascular disrupting agent ZD6126 in combination with paclitaxel
por: Martinelli, M, et al.
Publicado: (2007)

Heterogeneity of paclitaxel distribution in different tumor models assessed by MALDI mass spectrometry imaging
por: Giordano, Silvia, et al.
Publicado: (2016)

The Impact of the Immune System on Tumor: Angiogenesis and Vascular Remodeling
por: Stockmann, Christian, et al.
Publicado: (2014)

Determination of Paclitaxel Distribution in Solid Tumors by Nano-Particle Assisted Laser Desorption Ionization Mass Spectrometry Imaging
por: Morosi, Lavinia, et al.
Publicado: (2013)

Pseudo-resistance to anticancer drugs
por: Davoli, Enrico, et al.
Publicado: (2022)

Alveolar Hemorrhage Caused by the Combination of Immune Checkpoint Inhibitors (ICIs) and Angiogenesis Inhibitors: The Underlying Long-Term Vascular Endothelial Growth Factor (VEGF) Inhibition
por: Shijubou, Naoki, et al.
Publicado: (2022)

Nanoparticle Delivery and Tumor Vascular Normalization: The Chicken or The Egg?
por: Mattheolabakis, George, et al.
Publicado: (2019)

Role of Sirtuins in Tumor Angiogenesis
por: Edatt, Lincy, et al.
Publicado: (2020)

Editorial: Angiogenesis and tumor metastasis
por: Zhang, Qiang-Zhe, et al.
Publicado: (2023)

Combination of Serum Amyloid A and C-Reactive Protein Exhibit Synergistic Effect in Angiogenesis by Inducing Inflammation and Vascular Network
por: Liu, Dan, et al.
Publicado: (2020)

Angiogenesis Inhibitors in Small Cell Lung Cancer
por: Montanino, Agnese, et al.
Publicado: (2021)

Surgical Conversion for Initially Unresectable Locally Advanced Hepatocellular Carcinoma Using a Triple Combination of Angiogenesis Inhibitors, Anti-PD-1 Antibodies, and Hepatic Arterial Infusion Chemotherapy: A Retrospective Study
por: Zhang, Jinliang, et al.
Publicado: (2021)

Tumor vascular-targeted co-delivery of anti-angiogenesis and chemotherapeutic agents by mesoporous silica nanoparticle-based drug delivery system for synergetic therapy of tumor
por: Li, Xiaoyu, et al.
Publicado: (2015)

CDK 4/6 Inhibitors as Single Agent in Advanced Solid Tumors
por: Schettini, Francesco, et al.
Publicado: (2018)

Strategic Combination of DNA-Damaging Agent and PARP Inhibitor Results in Enhanced Cytotoxicity
por: Horton, Julie K., et al.
Publicado: (2013)

Case report: Pathological complete response to perioperative treatment of radiotherapy combined with angiogenesis inhibitor in a patient with pleomorphic liposarcoma
por: Zhang, Chenlu, et al.
Publicado: (2023)

WEE1 Inhibition in Combination With Targeted Agents and Standard Chemotherapy in Preclinical Models of Pancreatic Ductal Adenocarcinoma
por: Hartman, Sarah J., et al.
Publicado: (2021)

Tumor-Specific Delivery of Immune Checkpoint Inhibitors by Engineered AAV Vectors
por: Reul, Johanna, et al.
Publicado: (2019)

Vascular Permeability and Drug Delivery in Cancers
por: Azzi, Sandy, et al.
Publicado: (2013)

Combination of Radiofrequency Ablation With Resiquimod to Treat Hepatocellular Carcinoma Via Inflammation of Tumor Immune Microenvironment and Suppression of Angiogenesis
por: Tian, Zhou, et al.
Publicado: (2022)

Current Advances of Tubulin Inhibitors in Nanoparticle Drug Delivery and Vascular Disruption/Angiogenesis
por: Banerjee, Souvik, et al.
Publicado: (2016)

Integrated molecular profiling of patient‐derived ovarian cancer models identifies clinically relevant signatures and tumor vulnerabilities
por: Lupia, Michela, et al.
Publicado: (2022)

Immune Checkpoint Inhibitors Combined With Chemotherapy Compared With Chemotherapy Alone for Triple-Negative Breast Cancer: A Systematic Review and Meta-Analysis
por: Ji, Qiao, et al.
Publicado: (2021)

Endothelial YAP/TAZ Signaling in Angiogenesis and Tumor Vasculature
por: Hooglugt, Aukie, et al.
Publicado: (2021)

microRNAs Biogenesis, Functions and Role in Tumor Angiogenesis
por: Annese, Tiziana, et al.
Publicado: (2020)

Brain Tumor Microenvironment and Angiogenesis in Melanoma Brain Metastases
por: Trembath, Dimitri G., et al.
Publicado: (2021)

Medicago Sativa Defensin1 as a tumor sensitizer for improving chemotherapy: translation from anti-fungal agent to a potential anti-cancer agent
por: Pandurangi, Raghu, et al.
Publicado: (2023)

Identification of novel vascular markers through gene expression profiling of tumor-derived endothelium
por: Ghilardi, Carmen, et al.
Publicado: (2008)

Changes in Tumor-Infiltrating Lymphocytes and Vascular Normalization in Breast Cancer Patients After Neoadjuvant Chemotherapy and Their Correlations With DFS
por: Wang, Qiong, et al.
Publicado: (2020)

Targeted Delivery of Chemotherapeutic Agents for Osteosarcoma Treatment
por: Xie, Duoli, et al.
Publicado: (2022)

Therapeutic Potential of Combining PARP Inhibitor and Immunotherapy in Solid Tumors
por: Vikas, Praveen, et al.
Publicado: (2020)

Chemotherapy reinforces anti-tumor immune response and enhances clinical efficacy of immune checkpoint inhibitors
por: Zhang, Lin, et al.
Publicado: (2022)

Chemotherapy in Combination With Immune Checkpoint Inhibitors for the First-Line Treatment of Patients With Advanced Non-small Cell Lung Cancer: A Systematic Review and Literature-Based Meta-Analysis
por: Addeo, Alfredo, et al.
Publicado: (2019)

Natural Products: A Promising Therapeutics for Targeting Tumor Angiogenesis
por: Li, Ruyi, et al.
Publicado: (2021)

Novel Pathways for Targeting Tumor Angiogenesis in Metastatic Breast Cancer
por: Harry, Jordan A., et al.
Publicado: (2021)

Corrigendum: Changes in Tumor-Infiltrating Lymphocytes and Vascular Normalization in Breast Cancer Patients After Neoadjuvant Chemotherapy and Their Correlations With DFS
por: Wang, Qiong, et al.
Publicado: (2021)

Angiogenesis Inhibitors for Head and Neck Squamous Cell Carcinoma Treatment: Is There Still Hope?
por: Hyytiäinen, Aini, et al.
Publicado: (2021)

Immune Checkpoint Inhibitors Plus Single-Agent Chemotherapy for Advanced Non-Small-Cell Lung Cancer After Resistance to EGFR-TKI
por: Deng, Haiyi, et al.
Publicado: (2021)

Regulation of tumor angiogenesis by the crosstalk between innate immunity and endothelial cells
por: Ebeling, Svenja, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_82o5igihs5q50cchlq79t99d33